// App-Quantinova.ai

TCTAP A-141 : Procedural Safety and Intermediate Term Efficacy of Zotarolimus Eluting Resolute Integrity Stent in the Management of Native Very Long Segment Coronary Artery Lesion: A Prospective Observational Real World Study with 12-Month Follow-up

Researchers

Presenter

  • Soumya Patra

Principal Investigators

  • Rabindranath Chakraborty

  • Praskas Chandra Mandal

Medical Centers

  • Apollo Gleneagles Hospital, India

Locations

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Congestive heart failure

  • Acute Coronary Syndromes

  • Coronary Artery Disease

  • Myocardial infarction

  • Diabetes

  • Venous thrombosis

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • ZoMaxx

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved